MedTrace Logo

Effects of GCP on Prostate Cancer.

NCT00269555 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2010-06-29

No results posted yet for this study

Summary

Genistein Combined Polysaccharide (GCP) is derived from adding soy powder to shiitake mushrooms. This concentrated mixture is currently being sold in Japan and the United States and is thought to possibly contain properties that may be useful in treating certain types of cancer.

Conditions

Interventions

DRUG

Genistein Combined Polysaccharide (GCP)

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Robert Hackman, PhD · University of California, Davis

  • Ralph W deVere White, MD · University of California, Davis

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-05-31
Primary Completion
2006-01-31
Completion
2006-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00269555 on ClinicalTrials.gov